Leukotriene B4 licenses inflammasome activation to enhance skin host defense

Bethany Moore (University of Michigan, Ann Arbor, MI) for providing the MRSA USA300 LAC strain and Roger Plaut (Food and Drug Administration, Silver Spring, MD) for providing the bioluminescent USA300 (NRS384 lux) MRSA strain. This paper was supported by NIH Grants R01HL124159-01 and RAI149207A (to...

Descripción completa

Detalles Bibliográficos
Autores: Salina, Ana Carolina Guerta, Brandt, Stephanie L., Klopfenstein, Nathan, Blackman, Amondrea, Bazzano, Júlia Miranda Ribeiro, Nunes, Anderson Sá, Glosson, Nicole Byers, Brodskyng, Claudia Ida, Tavares, Natalia Machado, Silva, Icaro Bonyek Santos da, Medeiros, Alexandra I., Serezani, C. Henrique
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:Brasil
Institución:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Repositório Institucional da FIOCRUZ (ARCA)
Idioma:inglés
OAI Identifier:oai:arca.fiocruz.br:icict/45771
Acceso en línea:https://arca.fiocruz.br/handle/icict/45771
Access Level:acceso abierto
Palabra clave:Inflamassoma
Leucotrieno
Pele
Imunidade
Descripción
Sumario:Bethany Moore (University of Michigan, Ann Arbor, MI) for providing the MRSA USA300 LAC strain and Roger Plaut (Food and Drug Administration, Silver Spring, MD) for providing the bioluminescent USA300 (NRS384 lux) MRSA strain. This paper was supported by NIH Grants R01HL124159-01 and RAI149207A (to C.H.S.), T32AI060519 (to S.L.B.), and T32AI138932 (to N.K.); FAPESP Grants 2018/01622-9, 2017/04786-0 (to A.C.G.S.), 2017/19870-6 (to A.I.M.), and 2019/10839-4 (to A.S.-N.); and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001.

Similares en LA Referencia